Skip to main content
. 2020 Nov 20;20:218–226. doi: 10.1016/j.omtm.2020.11.010

Figure 5.

Figure 5

Immunohistochemical analysis of the distal colon of DSS-administered (8 days), psiTNF-treated (4 days) animals

(A) Distal colon of DSS-administered (8 days), psiTNF-treated (4 days) animals (mucosa, submucosa): psiTNF plasmid (GFP), Iba1+ mucosal macrophages (arrows), and epithelial cells (arrowheads). (B–D) Distal colon of DSS-administered (8 days), psiTNF-treated (4 days) animals (lymphatic aggregate in mucosa): psiTNF plasmid (GFP); GFP/IBA double-positive macrophages (arrowheads). (C and D) High-magnification images: Iba1+GFP+ (arrowheads) and Iba1+GFP macrophages (arrow in D). (E and F) Distal colon of DSS-administered (8 days), psiTNF-treated (4 days) animals (lymphatic aggregate in mucosa): psiTNF plasmid (GFP); GFP is expressed in CD45+Iba1+ mucosal macrophages (arrowheads in E); only pycnotic and ramified CD45/Iba1 double-positive macrophages express GFP, whereas CD45+Iba1 lymphocytes of round morphology show no plasmid incorporation (F). (G–I) Distal colon of DSS-administered (8 days), psiTNF-treated (4 days) animals (mucosa); psiTNF plasmid (GFP); F4/80+ mucosal macrophages and epithelial cells show strong TNF production (G). (H and I) Expression of TNF and GFP of F4/80+ mucosal macrophages in consecutive sections.